CareersPipelineCollaboration RareInnovation SVGOMG The best SVG optimizer and minifier Open SVG Paste markup Demo Contribute SVGOMG provides you several options to clean and compress your SVG files. Clean up, remove, merge, minify. Upload or copy the source of your SVG to get started! 947 bytes → 267 bytes 28.19% Finance peopleAdvance treatment Skip to main contentSkip to navigationSkip to search
HNSA   ( ,  %) SEK
Quotes are delayed 15 minutes
Antibodies

Science

Hansa Biopharma’s proprietary antibody-cleaving enzymes, imlifidase and HNSA-5487, target and inactivate IgG antibodies in the blood and tissues, inhibiting the IgG-mediated immune responses.

Antibodies, and in particular Immunoglobulin G (IgG) are an important element of the protective immune response. In some situations, however, IgGs can be pathogenic or harmful. In autoimmune conditions for example, the immune system mistakenly mounts an attack against the body’s own cells and tissues. In other instances, antibodies interfere with and undermine the success of gene therapies and certain procedures including transplantation.

With their rapid onset of action that temporarily reduces IgG below detectable level in 2-6 hours, imlifidase and HNSA-5487 help halt the progression of IgG-driven acute autoimmune diseases, as well as enable lifesaving and life altering procedures and therapies.